Corbus Pharmaceuticals Holdings Inc CRBP 深 沪
交易中 10-06 11:28:11 美东时间
5.83
-0.020
-0.34%
华盛通- 最 高11.60
- 今 开5.87
- 成交量 30.92万股
- 最 低 5.65
- 昨 收 5.85
- 总市值 72.88万
- 52周最高 20.56
- 市盈率 静 --
- 换手率 247.40%
- 52周最低 5.65
- 委 比 19.35%
- 总股本 0.00亿
- 历史最高 323.40
- 量 比 1.60
- 振 幅 101.71%
- 历史最低 1.50
- 每 手 1
- 风险率 2.48%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Corbus Pharmaceuticals Obesity Drug Avoids 'Depressive Effects'
Corbus Pharmaceuticals reports positive Phase 1b trial results for obesity drug CRB-913, demonstrating significant 12-week weight loss.
09-14 22:49
Market-Moving News for September 14th
GLW: -8% | Corning shares are trading lower after the company announced a $2 billion offering. ELMT: 49% | Elmet Group Lands $450M US Government Investment To Expand Tungsten Manufacturing, To Invest More Than $165M
09-14 19:21
Corbus Offers Upside Despite Post-FDA Update, Analyst Highlights Competitive Edge
Corbus reports FDA alignment on the CRB-701 path, as analysts flag upside tied to the head and neck cancer opportunity and obesity pipeline.
04-07 23:56
Corbus Pharmaceuticals Holdings shares are trading lower after the company announced a proposed public offering.
Corbus Pharmaceuticals Holdings shares are trading lower after the company anno...
2025-10-31 04:49
Corbus Pharmaceuticals to Present at the Jefferies Global Healthcare Conference
Corbus Pharmaceuticals CEO Yuval Cohen will present a corporate update at the Jefferies Global Healthcare Conference on June 4, 2025, and participate in investor meetings. The company focuses on oncology and obesity with a pipeline including CRB-701, CRB-601, and CRB-913.
2025-05-22 12:00
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Tenon Medical (NASDAQ:TNON) shares increased by 28.2% to $5.16 during ...
2024-09-25 22:42
Novo Nordisk's Monlunabant Data Drags Stocks Of Smaller Players
Novo Nordisk announced positive Phase 2a trial results for monlunabant, showing significant weight loss with a 10 mg dose. However, investors reacted to limited gains at higher doses. Corbus Pharmaceuticals and Skye Bioscience stocks dropped as all three companies explore CB1 inhibition in obesity treatment.
2024-09-21 03:18
Crude Oil Moves Higher; Sable Offshore Shares Slide
U.S. stocks traded mostly lower toward the end of trading, with the Nasdaq Comp...
2024-09-21 02:16
Gold Gains Over 1%; Battalion Oil Shares Spike Higher
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite fall...
2024-09-21 00:39
